(NX) Quanex Building Products - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7476191041
Spacers, Profiles, Screens, Seals, Hardware
Total Rating 36
Risk 73
Buy Signal -0.62
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.85% |
| Yield on Cost 5y | 1.49% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 93.9% |
| Payout Ratio | 14.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.2% |
| Relative Tail Risk | -13.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.15 |
| Alpha | -40.17 |
| Character TTM | |
|---|---|
| Beta | 1.285 |
| Beta Downside | 0.637 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.35% |
| CAGR/Max DD | -0.14 |
Description: NX Quanex Building Products January 21, 2026
Quanex Building Products Corp. (NYSE: NX) manufactures and distributes a broad portfolio of building-product components-including energy-efficient insulating glass spacers, vinyl profiles, window and door hardware, and specialty sealants-for OEMs across North America, Europe, and Asia. The company reaches customers via a mixed channel model of direct sales teams, independent agents, and distributors, and has operated since 1927 from its Houston headquarters.
Key metrics that shape its outlook include FY 2023 revenue of roughly $1.3 billion with an EBITDA margin near 10 %, and a backlog that tracks the health of U.S. housing starts-an industry driver that has been volatile due to recent interest-rate cycles. Additionally, the push for higher ENERGY STAR ratings is boosting demand for its low-U glass spacers, while raw-material cost inflation (e.g., vinyl resin) remains a near-term margin pressure.
For a deeper, data-driven valuation snapshot, you might explore the companys profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: -250.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.97 > 1.0 |
| NWC/Revenue: 15.90% < 20% (prev 26.48%; Δ -10.58% < -1%) |
| CFO/TA 0.08 > 3% & CFO 164.9m > Net Income -250.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.6m) vs 12m ago -3.02% < -2% |
| Gross Margin: 27.17% > 18% (prev 0.24%; Δ 2693 % > 0.5%) |
| Asset Turnover: 85.71% > 50% (prev 55.09%; Δ 30.63% > 0%) |
| Interest Coverage Ratio: -3.35 > 6 (EBITDA TTM -83.3m / Interest Expense TTM 55.8m) |
Altman Z'' 0.77
| A: 0.15 (Total Current Assets 573.8m - Total Current Liabilities 281.5m) / Total Assets 1.97b |
| B: 0.08 (Retained Earnings 164.7m / Total Assets 1.97b) |
| C: -0.09 (EBIT TTM -186.8m / Avg Total Assets 2.14b) |
| D: 0.10 (Book Value of Equity 129.8m / Total Liabilities 1.24b) |
| Altman-Z'' Score: 0.77 = B |
Beneish M -3.37
| DSRI: 0.72 (Receivables 205.4m/197.7m, Revenue 1.84b/1.28b) |
| GMI: 0.88 (GM 27.17% / 23.92%) |
| AQI: 0.83 (AQ_t 0.42 / AQ_t-1 0.51) |
| SGI: 1.44 (Revenue 1.84b / 1.28b) |
| TATA: -0.21 (NI -250.8m - CFO 164.9m) / TA 1.97b) |
| Beneish M-Score: -3.37 (Cap -4..+1) = AA |
What is the price of NX shares?
As of January 30, 2026, the stock is trading at USD 18.37 with a total of 545,831 shares traded.
Over the past week, the price has changed by -3.11%, over one month by +18.59%, over three months by +23.89% and over the past year by -17.02%.
Over the past week, the price has changed by -3.11%, over one month by +18.59%, over three months by +23.89% and over the past year by -17.02%.
Is NX a buy, sell or hold?
Quanex Building Products has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy NX.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 52.4% |
| Analysts Target Price | 28 | 52.4% |
| ValueRay Target Price | 18.2 | -1.1% |
NX Fundamental Data Overview January 27, 2026
P/E Forward = 8.6655
P/S = 0.4696
P/B = 1.1831
P/EG = 0.8126
Revenue TTM = 1.84b USD
EBIT TTM = -186.8m USD
EBITDA TTM = -83.3m USD
Long Term Debt = 665.3m USD (from longTermDebt, last quarter)
Short Term Debt = 43.0m USD (from shortTermDebt, last quarter)
Debt = 853.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 777.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.64b USD (862.9m + Debt 853.7m - CCE 76.0m)
Interest Coverage Ratio = -3.35 (Ebit TTM -186.8m / Interest Expense TTM 55.8m)
EV/FCF = 16.04x (Enterprise Value 1.64b / FCF TTM 102.3m)
FCF Yield = 6.23% (FCF TTM 102.3m / Enterprise Value 1.64b)
FCF Margin = 5.56% (FCF TTM 102.3m / Revenue TTM 1.84b)
Net Margin = -13.65% (Net Income TTM -250.8m / Revenue TTM 1.84b)
Gross Margin = 27.17% ((Revenue TTM 1.84b - Cost of Revenue TTM 1.34b) / Revenue TTM)
Gross Margin QoQ = 28.08% (prev 27.86%)
Tobins Q-Ratio = 0.83 (Enterprise Value 1.64b / Total Assets 1.97b)
Interest Expense / Debt = 1.58% (Interest Expense 13.5m / Debt 853.7m)
Taxrate = 43.63% (15.1m / 34.7m)
NOPAT = -105.3m (EBIT -186.8m * (1 - 43.63%)) [loss with tax shield]
Current Ratio = 2.04 (Total Current Assets 573.8m / Total Current Liabilities 281.5m)
Debt / Equity = 1.18 (Debt 853.7m / totalStockholderEquity, last quarter 726.2m)
Debt / EBITDA = -9.33 (negative EBITDA) (Net Debt 777.7m / EBITDA -83.3m)
Debt / FCF = 7.61 (Net Debt 777.7m / FCF TTM 102.3m)
Total Stockholder Equity = 854.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -11.70% (Net Income -250.8m / Total Assets 1.97b)
RoE = -29.36% (Net Income TTM -250.8m / Total Stockholder Equity 854.3m)
RoCE = -12.29% (EBIT -186.8m / Capital Employed (Equity 854.3m + L.T.Debt 665.3m))
RoIC = -6.63% (negative operating profit) (NOPAT -105.3m / Invested Capital 1.59b)
WACC = 5.80% (E(862.9m)/V(1.72b) * Re(10.65%) + D(853.7m)/V(1.72b) * Rd(1.58%) * (1-Tc(0.44)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 17.56%
[DCF Debug] Terminal Value 87.24% ; FCFF base≈82.0m ; Y1≈90.4m ; Y5≈116.0m
Fair Price DCF = 57.96 (EV 3.43b - Net Debt 777.7m = Equity 2.65b / Shares 45.7m; r=5.90% [WACC]; 5y FCF grow 11.64% → 2.90% )
EPS Correlation: -1.30 | EPS CAGR: 26.87% | SUE: 2.45 | # QB: 1
Revenue Correlation: 67.94 | Revenue CAGR: 17.56% | SUE: 3.12 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.45 | Chg30d=-0.022 | Revisions Net=-2 | Analysts=4
EPS current Year (2026-10-31): EPS=2.10 | Chg30d=-0.107 | Revisions Net=-3 | Growth EPS=-8.8% | Growth Revenue=+0.2%
EPS next Year (2027-10-31): EPS=2.42 | Chg30d=-0.257 | Revisions Net=-1 | Growth EPS=+15.3% | Growth Revenue=+2.3%
P/S = 0.4696
P/B = 1.1831
P/EG = 0.8126
Revenue TTM = 1.84b USD
EBIT TTM = -186.8m USD
EBITDA TTM = -83.3m USD
Long Term Debt = 665.3m USD (from longTermDebt, last quarter)
Short Term Debt = 43.0m USD (from shortTermDebt, last quarter)
Debt = 853.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 777.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.64b USD (862.9m + Debt 853.7m - CCE 76.0m)
Interest Coverage Ratio = -3.35 (Ebit TTM -186.8m / Interest Expense TTM 55.8m)
EV/FCF = 16.04x (Enterprise Value 1.64b / FCF TTM 102.3m)
FCF Yield = 6.23% (FCF TTM 102.3m / Enterprise Value 1.64b)
FCF Margin = 5.56% (FCF TTM 102.3m / Revenue TTM 1.84b)
Net Margin = -13.65% (Net Income TTM -250.8m / Revenue TTM 1.84b)
Gross Margin = 27.17% ((Revenue TTM 1.84b - Cost of Revenue TTM 1.34b) / Revenue TTM)
Gross Margin QoQ = 28.08% (prev 27.86%)
Tobins Q-Ratio = 0.83 (Enterprise Value 1.64b / Total Assets 1.97b)
Interest Expense / Debt = 1.58% (Interest Expense 13.5m / Debt 853.7m)
Taxrate = 43.63% (15.1m / 34.7m)
NOPAT = -105.3m (EBIT -186.8m * (1 - 43.63%)) [loss with tax shield]
Current Ratio = 2.04 (Total Current Assets 573.8m / Total Current Liabilities 281.5m)
Debt / Equity = 1.18 (Debt 853.7m / totalStockholderEquity, last quarter 726.2m)
Debt / EBITDA = -9.33 (negative EBITDA) (Net Debt 777.7m / EBITDA -83.3m)
Debt / FCF = 7.61 (Net Debt 777.7m / FCF TTM 102.3m)
Total Stockholder Equity = 854.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -11.70% (Net Income -250.8m / Total Assets 1.97b)
RoE = -29.36% (Net Income TTM -250.8m / Total Stockholder Equity 854.3m)
RoCE = -12.29% (EBIT -186.8m / Capital Employed (Equity 854.3m + L.T.Debt 665.3m))
RoIC = -6.63% (negative operating profit) (NOPAT -105.3m / Invested Capital 1.59b)
WACC = 5.80% (E(862.9m)/V(1.72b) * Re(10.65%) + D(853.7m)/V(1.72b) * Rd(1.58%) * (1-Tc(0.44)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 17.56%
[DCF Debug] Terminal Value 87.24% ; FCFF base≈82.0m ; Y1≈90.4m ; Y5≈116.0m
Fair Price DCF = 57.96 (EV 3.43b - Net Debt 777.7m = Equity 2.65b / Shares 45.7m; r=5.90% [WACC]; 5y FCF grow 11.64% → 2.90% )
EPS Correlation: -1.30 | EPS CAGR: 26.87% | SUE: 2.45 | # QB: 1
Revenue Correlation: 67.94 | Revenue CAGR: 17.56% | SUE: 3.12 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.45 | Chg30d=-0.022 | Revisions Net=-2 | Analysts=4
EPS current Year (2026-10-31): EPS=2.10 | Chg30d=-0.107 | Revisions Net=-3 | Growth EPS=-8.8% | Growth Revenue=+0.2%
EPS next Year (2027-10-31): EPS=2.42 | Chg30d=-0.257 | Revisions Net=-1 | Growth EPS=+15.3% | Growth Revenue=+2.3%